Search by Drug Name or NDC
NDC 00037-6860-10 Dipentum 250 mg/1 Details
Dipentum 250 mg/1
Dipentum is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Meda Pharmaceuticals Inc.. The primary component is OLSALAZINE SODIUM.
MedlinePlus Drug Summary
Olsalazine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) in adults when another medication (sulfasalazine) could not be tolerated. Olsalazine is in a class of medications called anti-inflammatory agents. Olsalazine reduces the bowel inflammation, diarrhea (stool frequency), rectal bleeding, and abdominal pain.
Related Packages: 00037-6860-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Olsalazine
Product Information
NDC | 00037-6860 |
---|---|
Product ID | 0037-6860_f463a4ea-ba23-47da-af7f-92c2d7367a82 |
Associated GPIs | 52500040100120 |
GCN Sequence Number | 015514 |
GCN Sequence Number Description | olsalazine sodium CAPSULE 250 MG ORAL |
HIC3 | D6F |
HIC3 Description | DRUG TX-CHRONIC INFLAM. COLON DX,5-AMINOSALICYLAT |
GCN | 33401 |
HICL Sequence Number | 005889 |
HICL Sequence Number Description | OLSALAZINE SODIUM |
Brand/Generic | Brand |
Proprietary Name | Dipentum |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | olsalazine sodium |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE, GELATIN COATED |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | OLSALAZINE SODIUM |
Labeler Name | Meda Pharmaceuticals Inc. |
Pharmaceutical Class | Aminosalicylate [EPC], Aminosalicylic Acids [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019715 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00037-6860-10 (00037686010)
NDC Package Code | 0037-6860-10 |
---|---|
Billing NDC | 00037686010 |
Package | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10) |
Marketing Start Date | 2015-05-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |